WHEN TIPS BECOMES A SURGICAL CHALLENGE: INTRAOPERATIVE SOLUTIONS DURING LIVER TRANSPLANTATION

Patricia Fernández Blanco:SERGAS,A Coruña,Spain|Dora Gómez Pasantes:SERGAS,A Coruña,Spain|Jose Ignacio Rivas Polo:SERGAS,A Coruña,Spain|Manuel Gómez Gutiérrez:SERGAS,A Coruña,Spain

CLINICAL UTILITY OF URINARY ETHYL GLUCURONIDE FOR LISTING DECISIONS AND POST-TRANSPLANT ALCOHOL MONITORING IN LIVER TRANSPLANT RECIPIENTS

Patricio Más-Serrano:Clinical Pharmacokinetics Unit, Pharmacy Department,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Teresa Pomares:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain|María Rodríguez:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Pablo Bellot:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Iván Herrera:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain|Ivan Beltrá:Clinical Pharmacokinetics Unit, Pharmacy Department,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Cayetano Miralles:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain|Paola Melgar:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Candido Alcázar:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Celia Villodre:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Mariano Franco:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Jose Manuel Ramia:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Sonia Pascual:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain

USEFULNESS OF PLASMA HALF-LIFE AND THE RUMACK–MATTHEW NOMOGRAM IN PREDICTING HEPATOTOXICITY AND THE NEED FOR LIVER TRANSPLANTATION

Patricio Más-Serrano:Clinical Pharmacokinetics Unit, Pharmacy Department,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Teresa Pomares:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain|María Rodríguez:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Pablo Bellot:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Iván Herrera:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain|Ivan Beltrá:Clinical Pharmacokinetics Unit, Pharmacy Department,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Cayetano Miralles:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain|Paola Melgar:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Candido Alcázar:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Celia Villodre:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Mariano Franco:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Jaime Botella:Clinical Pharmacokinetics Unit, Pharmacy Department,Dr. Balmis University General Hospital,Alicante,Spain|Ana Rodríguez:Clinical Pharmacokinetics Unit, Pharmacy Department,Dr. Balmis University General Hospital,Alicante,Spain|Jose Manuel Ramia:Hepatobiliary Surgery Unit, Department of General Surgery,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain|Sonia Pascual:Liver Unit, Department of Gastroenterology,Dr. Balmis University General Hospital,Alicante,Spain;Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation),Alicante,Spain

TO STUDY THE PULMONARY ASPIRATION RISK IN PATIENTS
COMING FOR ELECTIVE LIVER TRANSPLANT USING POINT OF
CARE ULTRASOUND – A PROSPECTIVE OBSERVATIONAL STUDY

Ashish APOLLO Malik:Anesthesia and Critical Care ,Indraprastha Apollo Hospital,Delhi ,India|Sanjeev Aneja :Anesthesia and Critical Care ,Indraprastha Apollo Hospital,Delhi ,India|Neerav Goyal:Liver Transplant Surgery,Indraprastha Apollo Hospital,Delhi ,India

ANESTHESIA FOR LIVER TRANSPLANT IN HYPERTROPHIC CARDIOMYOPATHY AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR PATIENT WITH VENO-VENOUS BYPASS

Chinnarat Pongpruksa:Anesthesiology,Cleveland Clinic,Cleveland,United States|Jacek Cywinski:Anesthesiology,Cleveland Clinic,Cleveland,United States|Mazhar Khalil:General Srgery,Cleveland Clinic,Cleveland,United States|Trisha McGinnis:Anesthesiology,Cleveland Clinic,Cleveland,United States

HEPATIC VEIN RECONSTRUCTION USING AUTOLOGOUS VENOUS GRAFTS IN LIVING DONOR LIVER TRANSPLANTATION: EXPANDED EXPERIENCE AND TECHNICAL REFINEMENT

Akihiko Ichida:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Nobuhisa Akamatsu:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Ryugen Takahashi:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Takehiro Chiyoda:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Yusuke Kazami:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Satoru Abe:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Yujiro Nishioka:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Takeshi Takamoto:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Yoshikuni Kawaguchi:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan|Kiyoshi Hasegawa:Artificial Organ and Transplantation Surgery Division, Department of Surgery, Graduate School of Medicine,The University of Tokyo,Tokyo,Japan

ASSESSMENT OF RIGHT VENTRICULAR RESERVE IN LIVER TRANSPLANT CANDIDATES WITH PULMONARY HYPERTENSION

Chinnarat Pongpruksa:Anesthesiology,Cleveland Clinic,Cleveland,United States|Jacek B. Cywinski:Anesthesiology,Cleveland Clinic,Cleveland,United States|Jamak Modaresi Esfeh:Gastroenterology and Transplant Hepatology,Cleveland Clinic,Cleveland,United States|Adriano R. Tonelli:General Surgery,Cleveland Clinic,Cleveland,United States|Matthew T. Siuba:Pulmonary Critical Care Medicine,Cleveland Clinic,Cleveland,United States

A SIMPLE PRE-TRANSPLANT RISK MODEL IDENTIFYING AGE, SMOKING, HEPATOCELLULAR CARCINOMA AND VASCULAR ISCHEMIC DISEASE AS KEY PREDICTORS OF POST-LIVER TRANSPLANT MORTALITY

Maria Senosiain Labiano:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,bilbao,Spain|Patricia Salvador Bengoechea:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|Eunate Muga Ibarreche:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|ander garcia sanmiguel:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|alex bausela sainz:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|Jose Ramón Fernandez ramos:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|francisco javier bustamante schneider:Gastroenterology,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|arkaitz perfecto valero:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|sara mambrilla:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|mikel prieto:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|palomares etxeberria:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|alberto ventoso castañeira:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|patricia ruiz ordorica:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain|mikel gastaca mateo:Surgery,Hospital Universitario Cruces,Bilbao,Spain;Biobizkaia,Bilbao,Spain

LONG-TERM OUTCOMES AFTER LIVER TRANSPLANTATION OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN A HIGH-VOLUME LIVER TRANSPLANT CENTER

Muhsin Murat Muhip Harputluoğlu:Transplant Hepatology,Inonu University Liver Transplant Institute,Malatya,Türkiye|Mücahid Uçak:Internal Medicine,Inonu University Medical Faculty,Malatya,Türkiye|Sezai Yilmaz:General Surgery,Inonu University Liver Transplant Institute,Malatya,Türkiye

RECIPIENT WARM ISCHEMIA AS A DETERMINANT OF EARLY GRAFT FAILURE AFTER LIVER TRANSPLANTATION: INTERACTION WITH HEMODYNAMIC INSTABILITY AND PORTAL INFLOW

Charles de Matteis:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Xavier Muller:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Fanny Lebosse:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Marie-Charlotte Delignette:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Guillaume Rossignol:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Teresa Antonini:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Jean Yves Mabrut:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France|Kayvan Mohkam:Hospices Civils de Lyon,Lyon,France;Lyon Hepatology Institute,Lyon,France